Patent pooling to increase access to essential medicines-Reference-Cited by-同舟云学术

Patent pooling to increase access to essential medicines

Published:2019-06-11 Issue:8 Volume:97 Page:575-577
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Burrone Esteban¹,Gotham Dzintars¹,Gray Andy²,de Joncheere Kees³,Magrini Nicola⁴,Martei Yehoda M⁵,Gore Charles¹,Kieny Marie Paule¹

Affiliation:

1. Medicines Patent Pool, 7 Rue de Varembé, 1202 Geneva, Switzerland.

2. Division of Pharmacology, University of KwaZulu-Natal, Durban, South Africa.

3. Netherlands Antibiotic Development Platform, University Medical Centre, Utrecht, Netherlands.

4. Essential Medicines and Health Products Department, World Health Organization, Geneva, Switzerland.

5. Hematology-Oncology Division, University of Pennsylvania, Philadelphia, United States of America.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference12 articles.

1. Antiretroviral therapy coverage (% of people living with HIV). Washington, DC: World Bank; 2017. Available from: https://data.worldbank.org/indicator/SH.HIV.ARTC.ZS [cited 2018 Jun 28].

2. Number of people receiving antiretroviral treatment [internet]. Geneva: World Health Organization; 2019. Available from: https://www.who.int/hiv/data/2017_ART-coverage-2000-2030.png [cited 2019 May 23].

3. Patent Pooling in Public Health

4. KPMG India statement on Medicines Patent Pool Foundation. Gurgaon: KPMG; 2019. Available from: https://medicinespatentpool.org/what-we-do/our-work/ [cited 2019 Jun 6].

5. WHO submission to the United Nations Secretary General high-level panel on access to medicines. Geneva: World Health Organization; 2016. Available from: https://static1.squarespace.com/static/562094dee4b0d00c1a3ef761/t/56e746279f7266a586c2b893/1457997352055/WHO_HLP_Submission_7Mar2016.pdf [cited 2018 Feb 16].

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response;Globalization and Health;2024-07-02

2. Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries;PLOS Global Public Health;2024-07-01

3. A Comprehensive Compulsory License under the WTO TRIPS: Lessons from the Covid-19 Pandemic;Journal of Korea Trade;2024-06-30

4. Refocusing the World Health Organization’s Model List of Essential Medicines on the needs of low and middle income countries;BMJ;2024-04-16

5. Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries;Epidemiology and Psychiatric Sciences;2024